Interleukin inhibitors
- ATC Codes
- Antineoplastic and immunomodulating agents
- Immunosuppressants drugs
- Immunosuppressants drugs
- Interleukin inhibitors
- L04AC01 : Daclizumab
- L04AC02 : Basiliximab
- L04AC03 : Anakinra
- L04AC04 : Rilonacept
- L04AC05 : Ustekinumab
- L04AC06 : Mepolizumab
- L04AC07 : Tocilizumab
- L04AC08 : Canakinumab
- L04AC09 : Briakinumab
- L04AC10 : Secukinumab
- L04AC11 : Siltuximab
- L04AC12 : Brodalumab
- L04AC13 : Ixekizumab
- L04AC14 : Sarilumab
- L04AC15 : Sirukumab
- L04AC16 : Guselkumab
- L04AC17 : Tildrakizumab
- L04AC18 : Risankizumab
- L04AC19 : Satralizumab
- L04AC20 : Netakimab
- L04AC21 : Bimekizumab
- L04AC22 : Spesolimab